Vivimusta Injection
Product Images NDC 24338-270

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vivimusta (NDC 24338-270). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Figure 1)

A Kaplan-Meier survival curve chart indicating progression-free survival (months) on the x-axis and survival distribution function on the y-axis. The chart compares two study treatments, Bendamustine Hydrochloride represented by a solid line, and Chlorambucil represented by a dashed line.*

FDA Label Image

Vivimusta Carton (Vivimusta Carton)

The image shows the packaging label for VIVIMUSTA bendamustine HCl injection, 100 mg/4 mL (25 mg/mL), a sterile 4 mL multiple-dose vial for intravenous infusion. The label includes storage instructions, dosage information, hazardous drug warnings, and manufacturer details for Azurity Pharmaceuticals, Inc. and Latina Pharma S.p.A. The label emphasizes dilution requirements prior to administration and displays multiple barcodes.*

FDA Label Image

Vivimusta Structure (Vivimusta Structure)

Chemical structure diagram of bendamustine hydrochloride showing its molecular arrangement including chlorine substituents, a benzimidazole ring, and carboxylic acid groups. The structure includes indications for hydrochloride and water of hydration (HCl and H2O).*

FDA Label Image

Vivimusta Vial (Vivimusta Vial)

Label for Vivimusta (bendamustine hydrochloride injection) 100 mg/4 mL (25 mg/mL) multiple-dose vial. The label states the drug must be diluted in a 250 mL admixture prior to intravenous infusion. It includes storage instructions (2°C to 8°C), manufacturer details (Azurity Pharmaceuticals, Inc. and Latina Pharma S.p.A.), and cautions about concentration and dilution requirements.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.